Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study

BACKGROUND: Ayurveda herbal formulation AYUSH-64, proven to treat malaria and influenza-like illness in india was repurposed for COVID-19 patients considering preliminary evidances, however, scientific data was not available. AIM: To evaluate the preliminary efficacy and safety of AYUSH 64 as an add...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakar, Anup, Goyal, Mandip, Bhinde, Sagar, Chhotala, Yagnik, Panara, Kalpesh, Chaudhari, Swapnil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114151/
https://www.ncbi.nlm.nih.gov/pubmed/35600633
http://dx.doi.org/10.1016/j.jaim.2022.100587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114151/
https://www.ncbi.nlm.nih.gov/pubmed/35600633
http://dx.doi.org/10.1016/j.jaim.2022.100587

Ejemplares similares